BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30210291)

  • 1. Gene Therapy in Mouse Models of Deafness and Balance Dysfunction.
    Wang L; Kempton JB; Brigande JV
    Front Mol Neurosci; 2018; 11():300. PubMed ID: 30210291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction.
    Wang L; Kempton JB; Jiang H; Jodelka FM; Brigande AM; Dumont RA; Rigo F; Lentz JJ; Hastings ML; Brigande JV
    Nucleic Acids Res; 2020 May; 48(9):5065-5080. PubMed ID: 32249312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.
    Hastings ML; Brigande JV
    Hear Res; 2020 Sep; 394():107931. PubMed ID: 32173115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid, Cost-Effective Method to Prepare Recombinant Adeno-Associated Virus for Efficient Gene Transfer to the Developing Mouse Inner Ear.
    Gomes MM; Wang L; Jiang H; Kahl CA; Brigande JV
    Methods Mol Biol; 2016; 1427():43-57. PubMed ID: 27259920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended time frame for restoring inner ear function through gene therapy in Usher1G preclinical model.
    Lahlou G; Calvet C; Simon F; Michel V; Alciato L; Plion B; Boutet de Monvel J; Lecomte MJ; Beraneck M; Petit C; Safieddine S
    JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38194286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse.
    Depreux FF; Wang L; Jiang H; Jodelka FM; Rosencrans RF; Rigo F; Lentz JJ; Brigande JV; Hastings ML
    Nucleic Acids Res; 2016 Nov; 44(20):9519-9529. PubMed ID: 27683224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Severity of Vestibular Dysfunction in Deafness as a Determinant of Comorbid Hyperactivity or Anxiety.
    Antoine MW; Vijayakumar S; McKeehan N; Jones SM; Hébert JM
    J Neurosci; 2017 May; 37(20):5144-5154. PubMed ID: 28438970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene editing based hearing impairment research and therapeutics.
    Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H
    Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges.
    Delmaghani S; El-Amraoui A
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
    Robertson NG; Cremers CW; Huygen PL; Ikezono T; Krastins B; Kremer H; Kuo SF; Liberman MC; Merchant SN; Miller CE; Nadol JB; Sarracino DA; Verhagen WI; Morton CC
    Hum Mol Genet; 2006 Apr; 15(7):1071-85. PubMed ID: 16481359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-Mediated Gene Delivery to the Inner Ear.
    Akil O; Lustig L
    Methods Mol Biol; 2019; 1950():271-282. PubMed ID: 30783980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness.
    Yoshimura H; Shibata SB; Ranum PT; Moteki H; Smith RJH
    Mol Ther; 2019 Mar; 27(3):681-690. PubMed ID: 30686588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV.
    György B; Sage C; Indzhykulian AA; Scheffer DI; Brisson AR; Tan S; Wu X; Volak A; Mu D; Tamvakologos PI; Li Y; Fitzpatrick Z; Ericsson M; Breakefield XO; Corey DP; Maguire CA
    Mol Ther; 2017 Feb; 25(2):379-391. PubMed ID: 28082074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory and vestibular mouse mutants: models for human deafness.
    Ahituv N; Avraham KB
    J Basic Clin Physiol Pharmacol; 2000; 11(3):181-91. PubMed ID: 11041382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery.
    Dai C; Lehar M; Sun DQ; Rvt LS; Carey JP; MacLachlan T; Brough D; Staecker H; Della Santina AM; Hullar TE; Della Santina CC
    J Assoc Res Otolaryngol; 2017 Aug; 18(4):601-617. PubMed ID: 28646272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction.
    Tao Y; Huang M; Shu Y; Ruprecht A; Wang H; Tang Y; Vandenberghe LH; Wang Q; Gao G; Kong WJ; Chen ZY
    Hum Gene Ther; 2018 Apr; 29(4):492-506. PubMed ID: 29130354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Delivery into the Inner Ear and Its Clinical Implications for Hearing and Balance.
    Kanzaki S
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A humanized mouse model, demonstrating progressive hearing loss caused by MYO6 p.C442Y, is inherited in a semi-dominant pattern.
    Wang J; Shen J; Guo L; Cheng C; Chai R; Shu Y; Li H
    Hear Res; 2019 Aug; 379():79-88. PubMed ID: 31103816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new mouse mutant, flouncer, with a balance defect and inner ear malformation.
    Pau H; Hawker K; Fuchs H; De Angelis MH; Steel KP
    Otol Neurotol; 2004 Sep; 25(5):707-13. PubMed ID: 15353999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zebrafish as a model for hearing and deafness.
    Whitfield TT
    J Neurobiol; 2002 Nov; 53(2):157-71. PubMed ID: 12382273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.